TPST (STOCKS)
Tempest Therapeutics, Inc. Common Stock
$2.040400
-0.009600 (-0.47%)
Prev close: $2.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew Angel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $30.70M
- Employees
- 5
- P/E (TTM)
- -0.31
- P/B (TTM)
- 1.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.62 | $-0.63 | +0.0124 | +1.96% |
|
Sep 2025 (Q3)
|
$-0.79 | $-3.34 | +2.5454 | +76.31% |
|
Jun 2025 (Q2)
|
$-2.07 | $-2.66 | +0.5871 | +22.10% |
|
Mar 2025 (Q1)
|
$-3.16 | $-3.36 | +0.1992 | +5.93% |
Financial Statements
| Nonoperating Income/Loss | $313.00K |
| Operating Income/Loss | -$26.58M |
| Income/Loss From Continuing Operations After Tax | -$26.26M |
| Income/Loss From Continuing Operations Before Tax | -$26.26M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$26.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.26M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.33 |
| Diluted Earnings Per Share | -$6.33 |
| Basic Average Shares | 4,149,733 |
| Diluted Average Shares | 4,149,733 |
| Assets | $16.93M |
| Current Assets | $8.27M |
| Prepaid Expenses | $196.00K |
| Other Current Assets | $8.07M |
| Noncurrent Assets | $8.66M |
| Fixed Assets | $605.00K |
| Other Non-current Assets | $8.06M |
| Liabilities | $10.26M |
| Current Liabilities | $3.31M |
| Accounts Payable | $1.04M |
| Interest Payable | $0.00 |
| Wages | $147.00K |
| Other Current Liabilities | $2.13M |
| Noncurrent Liabilities | $6.95M |
| Equity | $6.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.67M |
| Liabilities And Equity | $16.93M |
| Net Cash Flow From Operating Activities | -$26.82M |
| Net Cash Flow From Operating Activities, Continuing | -$26.82M |
| Net Cash Flow From Investing Activities | $22.56M |
| Net Cash Flow From Investing Activities, Continuing | $22.56M |
| Net Cash Flow From Financing Activities | $4.26M |
| Net Cash Flow From Financing Activities, Continuing | $4.26M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$26.26M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.26M |
| Other Comprehensive Income/Loss | $0.00 |